Schnieders Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Schnieders Capital Management's LLY Position: Q2 2026 in Review
Schnieders Capital Management increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $2.26M and bringing the position to 10,691 shares worth $12.8M. The position accounts for 1.68% of the portfolio, ranked #14.
Schnieders Capital Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 1,587 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Schnieders Capital Management held 10,691 shares of Eli Lilly worth $12.8M as of Q2 2026.
- Schnieders Capital Management bought 2,212 Eli Lilly shares in Q2 2026, an estimated $2.26M.
- Eli Lilly made up 1.68% of Schnieders Capital Management's portfolio in Q2 2026, its #14 holding.
- Schnieders Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 1,587 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Schnieders Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.